Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07227883 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Secretome Treatment for Facial Rejuvenation

StatusRecruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 70 wordsv6
  2. Site contact updatedv5
  3. Study description expanded, about 117 wordsv4
  4. Primary endpoints: 3 to 2
    • Start date changed from estimate of Dec 5, 2025 to Dec 15, 2025
    • Eligibility criteria revised
    v3
  5. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary and study completion dates: Nov 15, 2026 to Dec 20, 2026
    • Start date: Nov 25, 2025 to Dec 5, 2025
    • Eligibility criteria shortened, about 176 words
    • Site details revised
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Secretome treatment for facial rejuvenation
Trial Details
NCT Number NCT07227883
Lead Sponsor Acorn Biolabs Inc.
Conditions
(from sponsor)		 Facial Aging, Rejuvenation, Stem Cell, Stem Cell Banking
Related terms Facies
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov